Also, recent studies focused on such pathways, such as a report published in 2022 with two patients with autism spectrum disorders, language delay, cognitive impairment, and focal epilepsy associated with previously reported heterozygous de novo GRIN2A pathogenic variants [156]. The gene discussed is GRIN2A; the disease is autism spectrum disorder.